UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010228 |
|---|---|
| Receipt number | R000011975 |
| Scientific Title | Neoadjuvant chemotherapy with Paclitaxel/Bevacizumab followed by FEC (5-Fluorouracil/Epirubicin/Cyclophosphamide) for triple negative operable primary breast cancer |
| Date of disclosure of the study information | 2013/03/13 |
| Last modified on | 2018/08/03 11:07:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/03/13 01:24:58 | ||
| 2 | Update | 2014/03/13 14:56:43 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 3 | Update | 2014/03/13 15:07:15 | TEL Last name of contact person Last name of contact person TEL |
|
| 4 | Update | 2018/08/03 11:07:45 | Recruitment status |
